Adherence to Phosphodiesterase Type 5 Inhibitors in the Treatment of Erectile Dysfunction in Long-Term Users: How Do Men Use the Inhibitors?
Introduction: The high effectiveness of phosphodiesterase type 5 inhibitors (PDE5-i) in the treatment of erectile dysfunction (ED) has been demonstrated. However, previous research shows that PDE5-i treatments have high discontinuation rates. Aim: The main goals of this study were to (i) characteriz...
Main Authors: | Ana Carvalheira, PhD, Vera Forjaz, MSc, Nuno Monteiro Pereira, MD, PhD |
---|---|
Format: | Article |
Language: | English |
Published: |
Oxford University Press
2014-06-01
|
Series: | Sexual Medicine |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2050116115300301 |
Similar Items
-
Recreation use of phosphodiesterase type 5 inhibitors, the other side of erectile dysfunction
by: Giovanni Maria Fusco, et al.
Published: (2023-05-01) -
The Effect of Phosphodiesterase-type 5 Inhibitors on Erectile Function: An Overview of Systematic Reviews
by: Nikolaos Pyrgidis, et al.
Published: (2021-09-01) -
PDE-5 inhibitors in monotherapy versus combination therapy in a sample of 1200 patients with erectile dysfunction
by: Luis Labairu-Huerta, et al.
Published: (2015-09-01) -
Is There a Space to Improve the Treatment of Erectile Dysfunction in the Next Years? Opinion: No. Ten reasons that there will be no new pharmacologic therapies for erectile dysfunctionin the foreseeable future
by: Ira D. Sharlip
Published: (2015-10-01) -
Efficacy and safety of PDE5 inhibitors in middle-aged and old patients with and without hypogonadism
by: Chunlin Wang, et al.
Published: (2024-12-01)